Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess...
-
Upload
noah-bryan-scott -
Category
Documents
-
view
215 -
download
0
Transcript of Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess...
![Page 1: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/1.jpg)
Statistics and Medicine – Friends or Foes?
Monika Krzyzanowska MD MPHMedical Oncologist, Princess Margaret Cancer CentreAssociate Professor of Medicine, University of Toronto
![Page 2: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/2.jpg)
Case
• 61 year old male tailor• Presented with iron deficiency anemia• Colonoscopy: tumour in colon• Sent to general surgeon who removed the
primary cancer from the colon• The surgeon has referred the patient to you
(medical oncologist) for an opinion regarding what to do next?
![Page 3: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/3.jpg)
What do you need to know to advise the patient on next steps?
• How serious is the cancer?• What are the “treatment” options?• What are the benefits of treatment?• What are the risks?
![Page 5: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/5.jpg)
What do you need to know to advise the patient on next steps?
• How serious is the cancer?• What are the “treatment” options?• What are the benefits of treatment?• What are the risks?
![Page 6: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/6.jpg)
How serious is the cancer?
PROGNOSIS
![Page 7: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/7.jpg)
Colorectal Cancer Stages
![Page 8: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/8.jpg)
TNM Staging System
• T: depth of invasion into bowel wall– T1 Invasion of submucosa– T2 Invasion into muscularis propria– T3 Invasion through muscularis into serosa– T4 Invasion of other organs +/- perforation
• N: regional nodes– N0 No nodal mets– N1 Mets to 1-3 lymph nodes– N2 Mets in 4 nodes
• M: distant metastases
![Page 9: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/9.jpg)
TNM Staging System
TNM Classification Dukes’ Survival (no tx)
Stage I T1N0M0T2N0M0
A > 90%
Stage II IIAIIB
T3N0M0T4N0M0
B 60-85%
Stage III IIIAIIIBIIIC
T1-2N1M0T3-4N1M0anyTN2M0
C 25-65%
Stage IV anyTanyNM1 D 5%
![Page 10: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/10.jpg)
Case Revisited• CT scans – no spread of disease• Pathology
– Adenocarcinoma – invading through the muscularis into serosa– 7/15 LN involved with tumour
Stage: pT3N2M0 (Stage 3)
![Page 11: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/11.jpg)
TNM Staging
TNM Classification Dukes’ Survival (no tx)
Stage I T1N0M0T2N0M0
A > 90%
Stage II IIAIIB
T3N0M0T4N0M0
B 60-85%
Stage III IIIAIIIBIIIC
T1-2N1M0T3-4N1M0anyTN2M0
C 25-65%
Stage IV anyTanyNM1 D 5%
![Page 12: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/12.jpg)
Adjuvant! Online
https://www.newadjuvant.com/default2.aspx
![Page 13: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/13.jpg)
What do you need to know to advise the patient on next steps?
• How serious is the cancer?• What are the “treatment” options?• What are the benefits of treatment?• What are the risks?
![Page 14: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/14.jpg)
What are the treatment options?
• Do nothing• Surveillance• Chemotherapy
http://www.psmag.com/health/evidence-of-a-need-for-change-4241/
![Page 15: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/15.jpg)
Adjuvant Therapy
Treatment given after the primary treatment to increase the chances of a cure; may include chemotherapy, radiation therapy, hormone therapy, or biological therapy.
![Page 16: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/16.jpg)
What do you need to know to advise the patient on next steps?
• How serious is the cancer?• What are the “treatment” options?• What are the benefits of treatment?• What are the risks?
![Page 17: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/17.jpg)
Chemotherapy Options for St 3 Colon Cancer in 2013
• Drug A -- 5-fluorouracil (5-FU)
• Drug B – capecitabine
• Combination therapy (Drug A or B plus other drugs)
![Page 18: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/18.jpg)
Drug A vs No Treatment
![Page 19: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/19.jpg)
![Page 20: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/20.jpg)
![Page 21: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/21.jpg)
MOSAIC Trial
St II & III colon
n = 2,246
RANDOMIZATION
Combination
Drug A – 5FU
Andre NEJM 2004
![Page 22: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/22.jpg)
![Page 23: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/23.jpg)
![Page 25: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/25.jpg)
Adjuvant! Online
https://www.newadjuvant.com/default2.aspx
![Page 26: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/26.jpg)
What do you need to know to advise the patient on next steps?
• How serious is the cancer?• What are the “treatment” options?• What are the benefits of treatment?• What are the risks?
![Page 27: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/27.jpg)
MOSAIC Trial: Serious Toxicity
Toxicity 5FU FOLFOX
Neuropathy 0.2 12.4
Neutropenia 4.7 41.1
Diarrhea 6.6 10.7
Vomiting 1.4 5.8
Febrile neutropenia 0.2 1.8
Death 0.5 0.5
![Page 28: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/28.jpg)
MOSAIC Trial: Serious Toxicity
Toxicity 5FU FOLFOX
Neuropathy 0.2 12.4
Neutropenia 4.7 41.1
Diarrhea 6.6 10.7
Vomiting 1.4 5.8
Febrile neutropenia 0.2 1.8
Death 0.5 0.5
![Page 29: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/29.jpg)
Back to the Case
• 61 year old male tailor• Stage 3 colon cancer
What would you recommend?a. Do nothingb. Surveillance
c. Chemotherapy
![Page 30: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/30.jpg)
Evidence Based Medicine
![Page 31: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/31.jpg)
Guidelines
https://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=14002
![Page 32: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/32.jpg)
Guideline Concordance
![Page 33: Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,](https://reader035.fdocuments.us/reader035/viewer/2022062516/56649d8c5503460f94a73747/html5/thumbnails/33.jpg)
Statistics & Medicine• Explain & describe disease
– Natural history– Risk factors– Causes
• Evaluate treatments– Benefit– Risk
• Communicate with patient • Assess quality of care
Friends or Foes?